Sesen Bio Inc.
NASDAQ:SESN
Sesen Bio Inc. Stock, NASDAQ:SESN
245 First Street, Suite 1800, Cambridge, Massachusetts 02142
United States of America
Phone: +1.617.444.8550
Number of Employees: 27
Description
Sesen Bio, Inc. engages in designing, engineering, and developing of targeted protein therapeutics. It offers the Vicinium and Proxinium which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA.